THYROID CARCINOMA IN PENDRED’S SYNDROME
987
pital grant to P.K. The secretarial work of Maria Suzette Pott
and the laboratory expertise of Maria Silvia Cardia and Onur
Karamanoglu Arseven are gratefully acknowledged.
lecular analysis of the Pendred’s syndrome gene and mag-
netic resonance imaging studies of the inner ear are essen-
tial for the diagnosis of true Pendred’s syndrome. J Clin En-
docrinol Metab 85:2469–2475.
16. Najjar S 1963 Pendred’s syndrome in two families living in
endemic goitre area. BMJ 2:31–33.
References
17. Ferraris GM, Zoppetti G, Bidone G, Costa A 1966 Sindrome
del Pendred ed endemia di gozzo. Folia Endocrinol 9:295–312.
18. Almeida F, Temporal A, Cavalcanti N, Lins-Neto S, Albu-
querque R, Sá T 1974 Pendred’s syndrome in an area of en-
demic goiter in Brazil: Genetic and metabolic studies. In:
Dunn JT, Medeiros-Neto GA (eds) Endemic Goiter and Cre-
tinism—Continuing Threats to the World Health. Pan Amer-
ican Health Organization, Washington, D.C. pp 167–171.
19. Gausden E, Coyle B, Armour JA, Coffey R, Grossman A,
Fraser GR, Winter RM, Pembrey ME, Kendall-Taylor P,
Stephens D, Luxon LM, Phelps PD, Reardon W, Trembath
RC 1997 Pendred syndrome: evidence for genetic homo-
geneity and further refinement of linkage. J Med Genet 34:
126–129.
20. Hofstadter F 1980 Frequency and morphology of malignant
tumours of the thyroid before and after the introduction of
iodine-prophylaxis. Virchows Arch 385:263–270.
21. Studer H, Derwahl M 1995 Mechanisms of non-neoplastic
endocrine hyperplasia and hyperfunction: A changing con-
cept. Endocr Rev 16:411–426.
22. Vickery ALJ 1985 The diagnosis of malignancy in dyshormo-
genetic goitre. Clin Endocrinol Metab 10:317–335.
23. Medeiros-Neto G, Stanbury JB 1994 Thyroid malignancy and
dyshormogenetic goiter. In: Medeiros-Neto G, Stanbury JB
(eds) Inherited Disorders of the Thyroid System. CRC Press,
Boca Raton, pp 207–218.
24. Fagin JA 1996 Carcinoma of follicular epithelium. Molecular
pathogenesis. In: Braverman LE, Utiger RD (eds). The Thy-
roid. 7th ed. Lippincott-Raven, Philadelphia, pp 909–916.
25. Schroder S, Bocker W 1986 Clear cell carcinomas of the thy-
roid gland: A clinicopathological study of 13 cases. Histo-
pathology 10:75–89.
26. Bürgi U, Peter HJ, Gerber H 1996 Clinical manifestations and
management of nontoxic and diffuse and nodular goiter. In:
Braverman LE, Utiger RD (eds) The Thyroid. 7th ed. Lip-
pincott-Raven, Philadelphia, pp 896–900.
27. Pelizzo M, Bernante P, Toniato A, Fassiva A 1997 Frequency
of thyroid carcinoma in a recent series of 539 consecutive
thyroidectomies for multinodular goiter. Tumori 83:653–655.
28. Thieme ET 1957 A report of occurrence of deaf-mutism and
goiter in four of six siblings of a North American family.
Ann Surg 146:941–948.
29. Elman DS 1958 Familial association of nerve deafness with
nodular goiter and thyroid carcinoma. N Engl J Med 259:
219–223.
30. Watanabe I 1983 Dyshormogenesis. Hokumon to Rinsho
(Japanese). 31:627–636.
1. Medeiros-Neto G, Stanbury JB 1994 Pendred’s syndrome: as-
sociation of congenital deafness with sporadic goiter. In:
Medeiros-Neto G, Stanbury JB (eds) Inherited Disorders of
the Thyroid System. CRC Press, Boca Raton, pp 81–105.
2. Kopp P 1999 Pendred’s syndrome: Clinical characteristics and
molecular basis. Curr Concept Endocrinol Metab (in press).
3. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M,
Adawi F, Hazani E, Nasser E, Baxevanis AD, Sheffield VC,
Green ED 1997 Pendred syndrome is caused by mutations in
a putative sulphate transporter gene (PDS). Nat Genet
17:411–422.
4. Everett LA, Green ED 1999 A family of mammalian anion
transporters and their involvement in human genetic dis-
eases. Hum Mol Genet 8:1883–1891.
5. Scott DA, Wang R, Kreman TM, Sheffield VC, Karniski LP
1999 The Pendred syndrome gene encodes a chloride-iodide
transport protein. Nat Genet 21:440–443.
6. Sheffield VC, Kraiem Z, Beck JC, Nishimura D, Stone EM,
Salameh M, Sadeh O, Glaser B 1996 Pendred syndrome maps
to chromosome 7q21-34 and is caused by an intrinsic defect
in thyroid iodine organification. Nat Genet 12:424–426.
7. Li XC, Everett LA, Lalwani AK, Desmukh D, Friedman TB,
Green ED, Wilcox ER 1998 A mutation in PDS causes non-
syndromic deafness. Nat Genet 18:215–217.
8. Usami S, Abe S, Weston MD, Shinkawa H, van Camp G,
Kimberling WJ 1999 Nonsyndromic hearing loss associated
with enlarged vestibular aqueduct is caused by PDS muta-
tions. Hum Genet 104:188–192.
9. Fraser GR 1965 Association of congenital deafness with
goitre (Pendred’s syndrome). Ann Hum Genet 28:201–249.
10. Reardon W, Coffey R, Phelps PD, Luxon LM, Stephens D,
Kendall-Taylor P, Britton KE, Grossman A, Trembath R 1997
Pendred syndrome: 100 years of underascertainment. Q J
Med 90:443–447.
11. Coyle B, Reardon W, Herbrick JA, Tsui LC, Gausden E, Lee J,
Coffey R, Grueters A, Grossman A, Phelps PD, Luxon L,
Kendall-Taylor P, Scherer SW, Trembath RC 1998 Molecular
analysis of the PDS gene in Pendred syndrome (sensorineural
hearing loss and goitre). Hum Mol Genet 7:1105–1112.
12. Van Hauwe P, Everett LA, Coucke P, Scott DA, Kraft ML,
Ris-Stalpers C, Bolder C, Otten B, de Vijlder JJM, Dietrich
NL, Ramesh A, Sirsailapithy SCR, Parving A, Cremers
CWRJ, Willems PJ, Smith RJH, Green ED, Van Camp G 1998
Two frequent missense mutations in Pendred syndrome.
Hum Mol Genet 7:1099–1104.
13. Kopp P, Karamanoglu Arseven O, Sabacan L, Kotlar T,
Dupuis J, Cavaliere H, Santos CLS, Jameson JL, Medeiros-
Neto G 1999 Phenocopies for deafness and goiter develop-
ment in a large inbred kindred with Pendred’s syndrome
associated with a novel mutation in the PDS gene. J Clin En-
docrinol Metab 84:336–341.
14. Bogazzi F, Raggi F, Ultimieri F, Campomori A, Cosei C, Bar-
reti S, Neri E, La Rocca R, Ronca G, Martino E, Bartalena L
2000 A novel mutation in the pendrin gene associated with
Pendred’s syndrome. Clin Endocr 52:279–285.
31. Abs R, Verhelst J, Schoofs E, deSomer E 1991 Hyperfunc-
tioning metastatic follicular thyroid carcinoma in Pendred’s
syndrome. Cancer 67:2191–2193.
32. Mattos P, Bisi H, Medeiros-Neto G 1994 Dyshormogenetic
goiter: A pathological and immunohistochemical study. En-
docr Pathol 5:49–58.
33. Medeiros-Neto G, Gil-Da-Costa MJ, Santos CL, Medina AM,
Costa-e-Silva J, Tsou RM, Sobrinho-Simões M 1998 Meta-
static thyroid carcinoma arising from congenital goiter due
to mutation in the thyroperoxidase gene. J Clin Endocrinol
Metab 83:4162–4166.
15. Fugazzola L, Mannavola D, Cerutti N, Maghmie M, Pagella
F, Bianchi P, Weber G, Persani L, Beck-Peccoz P 2000 Mo-